At the heart of Bionxt's clinical strategy is a novel sublingual, orally dissolving film (ODF) formulation of the drug Cladribin. Cladribin is already an approved tablet therapy for Multiple Sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results